Cannabis Inhaler Market

Report ID : 1417 | Published : 2022-11-01 | Pages: 190 | Format: PDF/EXCEL

The market size of the global cannabis inhaler market is predicted to exhibit an 8.47% CAGR during the forecast period.

Cannabinoids are natural compounds present in Cannabis sativa plants. Aside from the health hazards associated with cannabis consumption, limited and well-monitored amounts of these cannabinoids may help with respiratory disorders such as Asthma and COPD. This is due to this psychoactive substance's bronchodilation characteristics. Asthma-like inhalers emit a mist containing cannabis and terpenes. These inhaled chemicals immediately enter the lungs' alveoli and spread throughout the body via the bloodstream. Owing to this and the medicinal benefits of cannabis, medical uses of these inhalers are being researched and developed, driving market growth. Demand for these inhalers is projected to rise in the long run as medical use of psychoactive substances becomes more acceptable worldwide. Various recreational applications are benefiting from this. The changing regulatory picture will drive this sector forward in the future. Compared to cigarettes, cannabis vaporizers are considered a safer, healthier, and less dangerous option. Compared to smoking, using a vaporizer offers a more pleasant experience, and many medical professionals advise it as one of the safest ways to consume cannabis. This would probably encourage the growth of the cannabis vaporizer sector globally. Additionally, users prefer to ingest cannabis through a vaporizer rather than smoking since it avoids cigarette chemicals, carcinogens, and respiratory irritants. This aspect raises the market's desire for cannabis vaporizers even more.


Since more patients are now looking for alternatives to smoking, the popularity of vaporization is also anticipated to impact market dynamics in the upcoming years. As they grow more dependable, affordable, and portable, medicinal cannabis vaping devices are becoming more and more popular. However, the lack of information regarding the long-term safety of cannabis used medicinally may limit the cannabis inhaler market's profit margins. Since there was a supply of fake drugs during the COVID-19 outbreak, public confidence in the medical community was damaged, which had a negative impact on sales of cannabis inhalers.

Market Segmentation:

The cannabis inhaler market is segmented by application. Based on the application, the market is segmented into asthma segment, wheezing, tightness in the chest and others.

Based on the application, the asthma segment category is accounted as a significant contributor to the cannabis inhaler market.

The asthma segment category dominated the market in 2021. It can enlarge and inflame airways, making asthma a potentially severe lung condition. It may cause wheezing, chest tightness, and shortness of breath. Bronchodilators can loosen the muscles constricting the airways, easing some asthmatic symptoms. A minor case of asthma could not even interfere with daily activities. It might occasionally result in a life-threatening assault.

The North American cannabis inhaler market holds a signification revenue share.

The North American cannabis inhaler market is expected to register the highest market share. Cannabis is prohibited because, if not used responsibly, it could lead to long-term consequences, including addiction. Federal legislation still forbids the purchase and use of cannabis in the US. However, on a state level, 36 US states have enacted legislation allowing the controlled use of cannabis for medical and recreational purposes. This is a crucial step in legalizing cannabis and will boost demand for cannabis inhalers in the US. In addition, Europe is projected to proliferate in the global cannabis inhaler market. Only licensed medical professionals may permit the patient to receive cannabis in the UK, Germany, and Cyprus because these countries have recognized marijuana as a prescription drug. This ensures patient safety and makes it simpler to identify the people who should be subject to legal action for cannabis sales. While countries like Sweden, Latvia, Belgium, and others have outright banned this chemical, making it illegal to import, purchase, or sell cannabis legally. This variant demonstrates how marijuana is only partially accepted in Europe. Europe is the second-largest market for cannabis inhalers; however, other European nations have highly stringent regulations and conditions.

Competitive Landscape

Key players in the cannabis inhaler market are CBD Luxe, Fairwinds cannabis, H and T presspart manufacturing LTD., Koi CBD, MUV and Vectura Group plc.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Cannabis Inhaler Market Snapshot

Chapter 4. Global Cannabis Inhaler Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Application Estimates & Trend Analysis

5.1. by Application & Market Share, 2019 & 2030

5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Application:

5.2.1. Asthma Segment

5.2.2. Wheezing

5.2.3. Tightness in Chest

5.2.4. Others

Chapter 6. Cannabis Inhaler Market Segmentation 2: Regional Estimates & Trend Analysis

6.1. North America

6.1.1. North America Cannabis Inhaler Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2030

6.1.2. North America Cannabis Inhaler Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2030

6.2. Europe

6.2.1. Europe Cannabis Inhaler Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2030

6.2.2. Europe Cannabis Inhaler Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2030

6.3. Asia Pacific

6.3.1. Asia Pacific Cannabis Inhaler Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2030

6.3.2. Asia Pacific Cannabis Inhaler Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2030

6.4. Latin America

6.4.1. Latin America Cannabis Inhaler Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2030

6.4.2. Latin America Cannabis Inhaler Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2030

6.5. Middle East & Africa

6.5.1. Middle East & Africa Cannabis Inhaler Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2030

6.5.2. Middle East & Africa Cannabis Inhaler Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2030

Chapter 7. Competitive Landscape

7.1. Major Mergers and Acquisitions/Strategic Alliances

7.2. Company Profiles

7.2.1. CBD Luxe

7.2.2. Fairwinds cannabis

7.2.3. H and T presspart manufacturing LTD.

7.2.4. Koi CBD

7.2.5. MUV

7.2.6. Vectura Group plc

7.2.7. Other Prominent Players

Segmentation of Cannabis Inhaler Market-

By Application-

  • Asthma Segment
  • Wheezing
  • Tightness in Chest
  • Others

By Region-

North America-

  • The US
  • Canada
  • Mexico


  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe


  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.


This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Our Clients

Media Citations

Growth opportunities and latent adjacency in Pharmaceuticals

Select Licence Type
Get a Custom Report
Contact us with a specific research request.

Kindly share us with a topic or product segment or objectives to meet your strategy goals

Review Request

We’ll review your request & send a personalized quote for cost and time needed

Final Delivery

Sit back while our team work on your research. We will send bi-monthly updates and discuss our finding on a conference call upon final delivery..